Effects of an Acute Dose of Caffeine on the Performance of CrossFit Athletes
Launched by DEMOCRITUS UNIVERSITY OF THRACE · Mar 17, 2025
Trial Information
Current as of April 26, 2025
Completed
Keywords
ClinConnect Summary
Preliminary measurements The preliminary measurements included anthropometry, body composition estimation, dietary and habitual caffeine consumption assessment. To assess habitual caffeine consumption, the volunteers were asked to answer a questionnaire through an interview, which investigated the typical consumption of specific caffeine-containing foods and beverages over the past month. Additionally, medical history information was collected through personal interviews.
Main tests Aerobic fitness and maximum heart rate were assessed using the 20-meter shuttle run at an indoor gymnasium. ...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Men
- • Aged 18-40
- • At least 2 years of experience with CrossFit programs
- • Free of any medical condition that prevents the participant from performing the exercises of the training program at maximum capacity
- Exclusion Criteria:
- • Consumption of caffeine and guarana supplements, unless were discontinued for at least two weeks before participating in the study
About Democritus University Of Thrace
Democritus University of Thrace is a leading academic institution in Greece, renowned for its commitment to advancing health sciences through innovative research and clinical trials. The university's research initiatives are driven by a multidisciplinary approach, fostering collaboration among experts in medicine, pharmacology, and biotechnology. With a focus on improving patient outcomes and contributing to the global body of medical knowledge, Democritus University of Thrace actively sponsors clinical trials that address critical health challenges, ensuring adherence to the highest ethical and scientific standards. Through its dedication to education and research, the university plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Athens, Byron, Greece
Patients applied
Trial Officials
ILIAS SMILIOS, Professor
Study Director
Democritus University of Thrace
VASSILIS MOUGIOS, Professor
Study Director
Aristotle University Of Thessaloniki
GREGORY C. BOGDANIS, Professor
Study Chair
Gregory C. Bogdanis National and Kapodistrian University of Athens, School of Physical Education and Sport Science
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported